Koers Yubo International Biotech Limited
Aandelen
YBGJ
US9883661004
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,95 USD | -0,78% | -0,78% | +216,67% |
Omzet 2022 | 0,1 0,1 | Omzet 2023 | 0,6 0,57 | Marktkapitalisatie | 35,95 mln. 33,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -939K | Nettowinst (verlies) 2023 | -1 mln. -939K | EV/omzet 2022 | 116.560.264 x |
Nettoschuld 2022 | 772K 725K | Nettoschuld 2023 | 386K 362K | EV/omzet 2023 | 60.084.725 x |
K/w-verhouding 2022 |
-9,36
x | K/w-verhouding 2023 |
-30
x | Werknemers | 20 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 6,63% |
1 dag | -0,78% | ||
1 week | -0,78% | ||
Lopende maand | -4,04% | ||
1 maand | +192,31% | ||
3 maanden | +216,67% | ||
6 maanden | +77,57% | ||
Lopend jaar | +216,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 01-01-19 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 01-01-19 |
Wang Yang
BRD | Director/Board Member | 45 | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 01-01-19 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 01-01-19 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 01-01-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+216,67% | 114 mln. | |
-1,82% | 41,35 mld. | |
+41,59% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |